UPDATE 1-U.S. top court grapples over making copycat biologics available sooner

WASHINGTON, April 26 (Reuters) - U.S. Supreme Court justices

on Wednesday struggled over whether to speed up the time it

takes to bring to the market copycat versions of biologic drugs,

expensive medicines that can generate billions of dollars in

sales for drug makers.

Read more